Variant report
Variant | rs322751 |
---|---|
Chromosome Location | chr7:127777057-127777058 |
allele | C/G |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:127776400-127777400 | Bivalent Enhancer | Fetal Thymus | thymus |
2 | chr7:127776400-127777400 | Enhancers | Spleen | Spleen |
3 | chr7:127776600-127777200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr7:127776600-127777200 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin01 | Skin |
5 | chr7:127776600-127777200 | Bivalent Enhancer | Monocytes-CD14+_RO01746 | blood |
6 | chr7:127776600-127777400 | Bivalent Enhancer | Primary Natural Killer cells fromperipheralblood | blood |
7 | chr7:127776600-127777400 | Enhancers | Pancreas | Pancrea |
8 | chr7:127776600-127777600 | Bivalent Enhancer | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr7:127776600-127777600 | Bivalent Enhancer | Primary hematopoietic stem cells short term culture | blood |
10 | chr7:127776600-127777600 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin02 | Skin |
11 | chr7:127776600-127777600 | Bivalent Enhancer | Fetal Muscle Leg | muscle |
12 | chr7:127776600-127777600 | Bivalent Enhancer | Placenta | Placenta |
13 | chr7:127776600-127778000 | Bivalent Enhancer | Primary monocytes fromperipheralblood | blood |
14 | chr7:127776800-127777600 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
15 | chr7:127776800-127777800 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
16 | chr7:127777000-127777800 | Bivalent Enhancer | HUVEC | blood vessel |